KM Biologics at a Glance
We are proud of our tireless pursuit of providing excellent healthcare for people around the world. Here is a brief outline of how we deliver on our promise.
First in the world
0
products
First Japanese-made
0
products
0
orphan drugs
approved by the Ministry of Health,
Labor and Welfare (Japan)
0
million vials of vaccines
shipped each year
Exciting innovations developed by our
0+
R&D staff
Pandemic influenza vaccines for
0
million people
0+
million newborn babies
screened since 1977
0
new or improved vaccines
in development as of Jun. 2023
*infographic statics as of September, 2023
KM Biologics joined
Meiji Group in 2018
One of the largest food and pharmaceutical companies in Japan
